glen's most recent trade in Alivus Life Sciences Ltd. was a Disposal of 7,800 Equity Shares done at an average price of Rs. 829.6 . Disclosure was reported to the exchange on July 15, 2024 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
glen's has made SAST transactions in Alivus Life Sciences Ltd. recently where a Pledge of 24,505,435 shares done . Disclosure was reported to the exchange on March 13, 2024.
Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alivus Life Sciences | Glenmark Pharmaceuticals Ltd | Promoter | Pledge | 24 Dec 2024 | 24,505,435 | 9,609,571 | 20% | - | 12 Mar 2024 12 Mar 2024 |
SAST (Reg31) | - | Release | |
Alivus Life Sciences | Glenmark Pharmaceuticals Ltd | Promoter | Disposal | 22 Jul 2024 | 9,609,571 | - | 7.84% | - | 11 Jul 2024 12 Jul 2024 |
SAST (29(2)) | - | Offer For Sale | |
Alivus Life Sciences | Glenmark Pharmaceuticals Ltd | Promoter | Non disposal undertaking | 17 Jul 2024 | 9,609,571 | 0 | - | - | 04 Jul 2024 04 Jul 2024 |
SAST (Reg31) | - | Release | |
Alivus Life Sciences | Glenn Mario Saldanha | Promoter Group | Disposal | 15 Jul 2024 | 7,800 | 0 (0%) | 0.01% | 829.6 | 6,471,076 | 11 Jul 2024 12 Jul 2024 |
Insider Trading | Equity Shares | Others |
Alivus Life Sciences | Glenmark Pharmaceuticals Limited | Promoter | Disposal | 15 Jul 2024 | 9,609,571 | 0 (0%) | 7.84% | 830.7 | 7,983,000,234 | 11 Jul 2024 12 Jul 2024 |
Insider Trading | Equity Shares | Others |
Alivus Life Sciences | Glenmark Pharmaceuticals Ltd | Promoter | Disposal | 19 Mar 2024 | 24,505,435 | 9,609,571 (7.84%) | 20% | - | 12 Mar 2024 12 Mar 2024 |
SAST (29(2)) | - | Off Market | |
Alivus Life Sciences | Glenmark Pharmaceuticals Ltd | Promoter | Disposal | 14 Mar 2024 | 67,389,944 | 34,115,006 (27.84%) | 55% | - | 06 Mar 2024 06 Mar 2024 |
SAST (29(2)) | - | Off Market | |
Alivus Life Sciences | Glenmark Pharmaceuticals Limited | Promoter | Disposal | 13 Mar 2024 | 24,505,435 | 9,609,571 (7.84%) | 20.00% | 598.0 | 14,654,095,299 | 12 Mar 2024 12 Mar 2024 |
Insider Trading | Equity Shares | Off Market |
Alivus Life Sciences | Glenmark Pharmaceuticals Limited | Promoter | Disposal | 07 Mar 2024 | 67,389,944 | 34,115,006 (27.84%) | 55.00% | 598.0 | 40,298,765,727 | 06 Mar 2024 06 Mar 2024 |
Insider Trading | Equity Shares | Off Market |
Alivus Life Sciences | Glenmark Pharmaceuticals Limited | Promoter | Pledge | 25 Sep 2023 | 9,609,571 | 101,504,950 (82.84%) | 7.84% | 615 | 5,909,886,165 | 21 Sep 2023 21 Sep 2023 |
Insider Trading | Equity Shares | Others |
Alivus Life Sciences | GLENN SALDANHA | Promoter Group | Acquisition | 17 Nov 2021 | 7,505 | 7,800 (0%) | 0.01% | 643.2 | 4,827,124 | 16 Nov 2021 16 Nov 2021 |
Insider Trading | Equity Shares | Market Purchase |
Alivus Life Sciences | GLENN SALDANHA | Promoter Group | Acquisition | 17 Nov 2021 | 295 | 295 (0%) | 0.00% | 640.8 | 189,026 | 15 Nov 2021 15 Nov 2021 |
Insider Trading | Equity Shares | Market Purchase |
Glenmark Pharma | GLENN SALDANHA | Promoter | Acquisition | 27 Sep 2021 | 9,800 | 983,439 (0.35%) | 0.00% | 513.0 | 5,027,549 | 24 Sep 2021 24 Sep 2021 |
Insider Trading | Equity Shares | Market Purchase |
Glenmark Pharma | GLENN SALDANHA | Promoter | Acquisition | 28 Jun 2021 | 7,800 | 973,639 (0.35%) | 0.00% | 640 | 4,992,000 | 23 Jun 2021 23 Jun 2021 |
Insider Trading | Equity Shares | Market Purchase |
Glenmark Pharma | GLENN SALDANHA | Promoter | Acquisition | 24 Jun 2021 | 2,800 | 965,839 (0.34%) | 0.00% | 641.9 | 1,797,197 | 22 Jun 2021 22 Jun 2021 |
Insider Trading | Equity Shares | Market Purchase |
Glenmark Pharma | GLENN SALDANHA | Promoter | Acquisition | 12 Jun 2021 | 6,500 | 963,039 (0.34%) | 0.00% | 636.8 | 4,139,470 | 09 Jun 2021 09 Jun 2021 |
Insider Trading | Equity Shares | Market Purchase |
Glenmark Pharma | GLENN SALDANHA | Promoter | Acquisition | 12 Jun 2021 | 1,370 | 956,539 (0.34%) | 0.00% | 636.8 | 872,473 | 09 Jun 2021 09 Jun 2021 |
Insider Trading | Equity Shares | Market Purchase |